Hasty Briefsbeta

  • #Lithium
  • #Alzheimer’s
  • #Neurodegeneration
  • Harvard researchers found that lithium deficiency in the brain may trigger Alzheimer’s disease.
  • Lithium naturally protects against neurodegeneration and supports brain cell function.
  • Amyloid beta plaques in Alzheimer’s bind to lithium, reducing its availability in the brain.
  • A new lithium compound, lithium orotate, reversed Alzheimer’s-like symptoms in mice without toxicity.
  • Early-stage Alzheimer’s patients showed significantly lower lithium levels compared to healthy individuals.
  • Lithium depletion in mice accelerated brain aging, inflammation, and cognitive decline.
  • Lithium orotate restored memory and prevented disease progression in mice, even at low doses.
  • Monitoring lithium levels could help in early Alzheimer’s diagnosis and prevention.
  • Existing lithium-based drugs for bipolar disorder use toxic doses, unlike the low-dose lithium orotate.
  • Further clinical trials are needed to validate lithium’s efficacy and safety in humans.